TrialThe New England journal of medicine2023

Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.

Patricia Winokur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.